Linaclotide API Powder to Treat Gastrointestinal Disorders CAS NO.851199-59-2

The first listed company in peptides industry, mature process, stable and advaced technology,API capacity reachease to 500kg with 3 main factory sites.

Linaclotide

Product Description

CAS Registry Number: 851199-59-2

Molecular Formula: C₅₉H₇₉N₁₅O₂₁S₆
Molecular Weight: 1526.8

Density:  1.6 g/cm3 

Boiling point: 2045.0 °C at 760 mmHg 

Appearance:white or off-white crystalline powder

Purity: 98% MIN

Linaclotide is a once-daily, orally administered, first-in-class agonist of guanylate cyclase-C that is minimally absorbed. It is being developed to treat gastrointestinal disorders. Linaclotide has received its first global approval in the US for the treatment of constipation-predominant irritable bowel syndrome (IBS-C) and chronic idiopathic constipation (CIC), and a marketing submission has been filed in the EU for IBS-C. This article summarizes the milestones in the development of linaclotide leading to this first approval for IBS-C and CIC.

FAQ

Q1. Are you a trade company or manufactures

A: We are an GMP approved manufacturer specialized in peptides API products, OEM is available, Key products have obtained USDMF and EDMF. Production lines passed US and EU Authorities audit.

Q2. What is your MOQ

A: We support trial order, 1g is min. 

Q3. What is your delivery date

A: Can be shipped within 2days after payment.

Q4. What is your payment term

A: T/T, LC.

Q5. Which country is your products sold

A: Our products sold worldwide expecially to Europe, North America, South America and Africa.